Fibroblast growth factors, their receptors and signaling.
TLDR
FGF signaling also appears to play a role in tumor growth and angiogenesis, and autocrine FGF signaling may be particularly important in the progression of steroid hormone-dependent cancers to a hormone-independent state.Abstract:
Fibroblast growth factors (FGFs) are small polypeptide growth factors, all of whom share in common certain structural characteristics, and most of whom bind heparin avidly. Many FGFs contain signal peptides for secretion and are secreted into the extracellular environment, where theycan bind to the heparan-like glycosaminoglycans (HLGAGs) of the extracellular matrix (ECM). From this reservoir, FGFs mayact directlyon target cells, or theycan be released through digestion of the ECM or the activityof a carrier protein, a secreted FGF binding protein. FGFs bind specific receptor tyrosine kinases in the context of HLGAGs and this binding induces receptor dimerization and activation, ultimatelyresulting in the activation of various signal transduction cascades. Some FGFs are potent angiogenic factors and most playimportant roles in embry onic development and wound healing. FGF signaling also appears to playa role in tumor growth and angiogenesis, and autocrine FGF signaling maybe particularlyimportant in the progression of steroid hormone-dependent cancers to a hormone-independent state.read more
Citations
More filters
Journal ArticleDOI
FGFR as potential target in the treatment of squamous non small cell lung cancer
Marcello Tiseo,Francesco Gelsomino,Roberta Alfieri,Andrea Cavazzoni,Cecilia Bozzetti,Annamaria De Giorgi,Pier Giorgio Petronini,Andrea Ardizzoni +7 more
TL;DR: This review summarizes the current knowledge about FGFR alterations in NSCLC and the relative inhibitors in development, in particular in squamous NSLI, and identifies and evaluates promising FGFR inhibitors.
Journal ArticleDOI
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
Friederike Göke,Maike Bode,Alina Franzen,Robert Kirsten,Diane Goltz,Antonia Göke,Rakesh Sharma,Diana Boehm,Wenzel Vogel,Patrick L. Wagner,Claudia Lengerke,Glen Kristiansen,Jutta Kirfel,Tobias van Bremen,Friedrich Bootz,Lynn E. Heasley,Andreas Schröck,Sven Perner +17 more
TL;DR: The data identify fibroblast growth factor receptor 1 amplification as a frequent event in primary and metastatic head and neck squamous cell carcinoma and represents a potential biomarker for more aggressive disease.
Journal ArticleDOI
ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers.
TL;DR: An analysis of 18 published gene expression data sets from different cancers shows that overexpression of ALK, its smaller homolog LTK and the ligands PTN and MK in cancer tissues from patients correlate significantly with worse course and outcome of the disease.
Journal ArticleDOI
90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.
TL;DR: The interaction of nuclear FGFR1 with pluripotent RSK1 offers a new mechanism through whichFGFR1 may control fundamental cellular processes.
Journal ArticleDOI
Molecular Insights and Novel Approaches For Targeting Tumor Metastasis
Sabya Sachi Das,Saad Alkahtani,Priyanshu Bharadwaj,Mohammed Tahir Ansari,Muneera D.F. AlKahtani,Zhiqing Pang,Saquib Hasnain,Amit Kumar Nayak,Tejraj M. Aminabhavi +8 more
TL;DR: In this review, various approaches for efficient targeting of pharmacologically active chemotherapeutics against tumor metastasis with the cohesive objectives of prognosis, tracking and therapy are summarized.
References
More filters
Journal ArticleDOI
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
TL;DR: It is demonstrated that free heparin and heparan sulfate can reconstitute a low affinity receptor that is, in turn, required for the high affinity binding of bFGF.
Journal ArticleDOI
Protein modules and signalling networks
TL;DR: This work highlights conserved protein domains that act as key regulatory participants in many of these different signalling pathways in multicellular organisms.
Journal ArticleDOI
Thalidomide is an inhibitor of angiogenesis.
TL;DR: Electron microscopic examination of the corneal neovascularization of thalidomide-treated rabbits revealed specific ultrastructural changes similar to those seen in the deformed limb bud vasculature of Thalidomid-treated embryos.
Journal ArticleDOI
Receptor specificity of the fibroblast growth factor family.
David M. Ornitz,Jingsong Xu,Jennifer S. Colvin,Donald G. McEwen,Craig A. MacArthur,François Coulier,Guangxia Gao,Mitchell Goldfarb +7 more
TL;DR: It is demonstrated that FGF 1 is the only FGF that can activate all FGF receptor splice variants and the relative activity of all the other members of the FGF family is determined.